The Blood Filtration and Purification Market was valued at USD 3.67 Billion in 2024, and is projected to reach USD 5.63 Billion by 2030, rising at a CAGR of 7.34%. Key driving factors such as increasing prevalence of blood-borne diseases, growing geriatric population, rising awareness of blood purification therapies have fueled the market growth.
The blood filtration & purification industry in clinical diagnostics experienced a major surge during the COVID-19 pandemic, driven by the urgent need for effective treatment solutions for critically ill patients. Among the most vital tools during this period were advanced blood purification kits, which played a critical role in managing severe inflammatory responses, organ failure, and complications associated with the virus.
At the forefront of this innovation was OXIRIS, a multifunctional blood purification filter set - the only one available in the U.S. capable of performing Continuous Renal Replacement Therapy (CRRT) while simultaneously removing cytokines and inflammatory mediators from the blood. During the height of the pandemic, OXIRIS became a key therapeutic solution for managing critically ill COVID-19 patients who were experiencing cytokine storms, sepsis, and acute kidney injury. By efficiently removing inflammatory substances, the kit helped stabilize patients, reduce intensive care burden, and improve survival outcomes.
Thermo Scientific's GeneJET Whole Blood Genomic DNA Purification Mini Kit stands out for its rapid, spin-column-based silica membrane technology. This kit streamlines DNA extraction from whole blood, eliminating the need for hazardous phenol-chloroform extraction or time-consuming alcohol precipitation. With a standard protocol that takes under 20 minutes post-lysis, it delivers high molecular weight DNA (>30 kb), ready for downstream applications like PCR, Southern blotting, and enzymatic assays. The kit’s simplicity and reliability make it a preferred choice for laboratories looking to scale genomic diagnostics with speed and safety.
SpiNXT Blood DNA Extraction Kit is another innovative solution, designed for use with whole blood, plasma, serum, lymphocytes, and buffy coat. Combining silica-binding chemistry with a mini spin-column format, it ensures high-yield, high-purity DNA isolations across a range of blood-derived sample types. With no need for organic solvents or complicated equipment, the SpiNXT kit enables fast processing and compatibility with a wide array of clinical genetic assays.
Meanwhile, the sbeadex Blood DNA Purification Kit brings magnetic bead-based technology into focus. Designed for sample volumes up to 200 µL, the kit supports high-throughput automation workflows and is fully compatible with popular platforms like Thermo Fisher's KingFisher™ system. Its water-based wash buffers help eliminate carryover of organic solvents and PCR inhibitors, ensuring clean DNA suitable for sensitive applications such as qPCR, NGS, Sanger sequencing, and genetic disorder screening.
The pandemic highlighted the critical role of blood purification kits in managing high-risk patients. As healthcare systems adapted to the challenges of COVID-19, these kits became indispensable tools not only for diagnostic support but also for therapeutic intervention. Their impact has extended beyond the pandemic, with continued use in managing sepsis, kidney injury, and other inflammation-driven conditions.
The COVID-19 crisis accelerated the adoption of blood filtration and purification kits such as OXIRIS, CytoSorb, AMBER, and Hemoclear, setting a new benchmark for integrated clinical diagnostics and critical care. These innovations remain central to modern ICU practice, ensuring that the lessons learned during the pandemic translate into stronger, more responsive healthcare systems going forward.
This product will be delivered within 2 business days.
The blood filtration & purification industry in clinical diagnostics experienced a major surge during the COVID-19 pandemic, driven by the urgent need for effective treatment solutions for critically ill patients. Among the most vital tools during this period were advanced blood purification kits, which played a critical role in managing severe inflammatory responses, organ failure, and complications associated with the virus.
At the forefront of this innovation was OXIRIS, a multifunctional blood purification filter set - the only one available in the U.S. capable of performing Continuous Renal Replacement Therapy (CRRT) while simultaneously removing cytokines and inflammatory mediators from the blood. During the height of the pandemic, OXIRIS became a key therapeutic solution for managing critically ill COVID-19 patients who were experiencing cytokine storms, sepsis, and acute kidney injury. By efficiently removing inflammatory substances, the kit helped stabilize patients, reduce intensive care burden, and improve survival outcomes.
Thermo Scientific's GeneJET Whole Blood Genomic DNA Purification Mini Kit stands out for its rapid, spin-column-based silica membrane technology. This kit streamlines DNA extraction from whole blood, eliminating the need for hazardous phenol-chloroform extraction or time-consuming alcohol precipitation. With a standard protocol that takes under 20 minutes post-lysis, it delivers high molecular weight DNA (>30 kb), ready for downstream applications like PCR, Southern blotting, and enzymatic assays. The kit’s simplicity and reliability make it a preferred choice for laboratories looking to scale genomic diagnostics with speed and safety.
SpiNXT Blood DNA Extraction Kit is another innovative solution, designed for use with whole blood, plasma, serum, lymphocytes, and buffy coat. Combining silica-binding chemistry with a mini spin-column format, it ensures high-yield, high-purity DNA isolations across a range of blood-derived sample types. With no need for organic solvents or complicated equipment, the SpiNXT kit enables fast processing and compatibility with a wide array of clinical genetic assays.
Meanwhile, the sbeadex Blood DNA Purification Kit brings magnetic bead-based technology into focus. Designed for sample volumes up to 200 µL, the kit supports high-throughput automation workflows and is fully compatible with popular platforms like Thermo Fisher's KingFisher™ system. Its water-based wash buffers help eliminate carryover of organic solvents and PCR inhibitors, ensuring clean DNA suitable for sensitive applications such as qPCR, NGS, Sanger sequencing, and genetic disorder screening.
The pandemic highlighted the critical role of blood purification kits in managing high-risk patients. As healthcare systems adapted to the challenges of COVID-19, these kits became indispensable tools not only for diagnostic support but also for therapeutic intervention. Their impact has extended beyond the pandemic, with continued use in managing sepsis, kidney injury, and other inflammation-driven conditions.
The COVID-19 crisis accelerated the adoption of blood filtration and purification kits such as OXIRIS, CytoSorb, AMBER, and Hemoclear, setting a new benchmark for integrated clinical diagnostics and critical care. These innovations remain central to modern ICU practice, ensuring that the lessons learned during the pandemic translate into stronger, more responsive healthcare systems going forward.
Blood Filtration and Purification Market Report Highlights
- The filtration kits & reagents segment led the market with the largest revenue share of 35.97% in 2024. This segment is expected to see rapid expansion due to its critical role in ensuring the safety and efficacy of blood transfusions, therapeutic treatments, and medical research. A key driving factor is the technological advancements in filtration materials, and a growing global demand for high-quality blood products further contributes to the dominance of filtration kits and reagents in the market.
- Based on application, the infectious disease diagnostics segment accounted for the largest market revenue share in 2024, due to the growing global prevalence of infectious diseases and the critical need for accurate, rapid diagnostics. The genetic/molecular diagnostics segment is expected to grow at the fastest CAGR over the forecast period, due to the increasing demand for precise, personalized healthcare solutions.
- Based on end use, the clinical diagnostics laboratories segment accounted for the largest market revenue share in 2024, due to their essential role in disease detection and monitoring. These laboratories rely on advanced filtration technologies to obtain high-quality, contaminant-free blood samples for accurate testing, especially in infectious disease diagnostics, genetic testing, and oncology. With the rise of personalized medicine and early disease detection, clinical diagnostic labs are adopting cutting-edge filtration technologies, driving both the size and growth of this market segment.
Why Should You Buy This Report?
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listings for you to stay ahead of the curve
This product will be delivered within 2 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Blood Filtration & Purification Market Variables, Trends & Scope
Chapter 4. Blood Filtration & Purification Market: Product Estimates & Trend Analysis
Chapter 5. Blood Filtration & Purification Market: Application Estimates & Trend Analysis
Chapter 6. Blood Filtration & Purification Market: End-use Estimates & Trend Analysis
Chapter 7. Blood Filtration & Purification Market: Regional Estimates & Trend Analysis by Product, Application and End-use
Chapter 8. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
The companies profiled in this Blood Filtration and Purification market report include:- Thermo Fischer Scientific
- MilliporeSigma
- Roche lifescience
- Sigma Aldrich
- Avantor
- Takara Bio
- MP Biomedicals.
- QIAGEN N.V
- HiMedia
- Biotage
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 125 |
| Published | April 2025 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 3.67 Billion |
| Forecasted Market Value ( USD | $ 5.63 Billion |
| Compound Annual Growth Rate | 7.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 11 |
